Roche Holding AG (OTCQX International Premier:RHHBY)

35.44
Delayed Data
As of Apr 17
 -0.55 / -1.53%
Today’s Change
32.08
Today|||52-Week Range
38.15
+4.27%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$195.6B

Company Description

Roche Holding AG is a research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. It operates business through two divisons: Pharmaceuticals and Diagnostics. The Pharmaceuticals divison comprises the two business segments Roche Pharmaceuticals and Chugai, whereas Genentech as the former third segment has been integrated into Roche Pharmaceuticals. The Diagnostics Division consists of the following four business areas: Diabetes care, Molecular diagnostics, Professional diagnostics and Tissue diagnostics. The company was founded by Fritz Hoffmann-La Roche in 1896 and is headquartered in Basel, Switzerland.

Contact Information

Roche Holding AG
Grenzacherstrasse 124
Basel Basel-stadt (basle Town) 4070
P:(161) 688-1111
Investor Relations:
(161) 687-8503

Employees

Shareholders

Mutual fund holders1.71%
Other institutional0.48%
Individual stakeholders--

Top Executives

Severin SchwanChief Executive Officer & Executive Director
Alan HippeChief Financial & Information Technology Officer
John C. ReedHead-Roche Pharma Research & Early Development
Michael D. VarneyHead-Genentech Research & Early Development
Stephan FeldhausHead-Group Communications

To view my watchlist

Not a member yet?

Sign up now for a free account